This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Amgen Inc.
Reference
Urbich M, et al. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020). PharmacoEconomics : 19 Aug 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00952-0
Rights and permissions
About this article
Cite this article
Hospitalisation key driver of costs associated with heart failure in the US. PharmacoEcon Outcomes News 861, 17 (2020). https://doi.org/10.1007/s40274-020-7099-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7099-4